Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa

Journal of Investigative Dermatology

Volumn 134, Issue 5, 2014, Pages 1246-1254

  Tolar, Jakub ^a   McGrath, John A ^b   Xia, Lily ^a   Riddle, Megan J ^a   Lees, Chris J ^a   Eide, Cindy ^a   Keene, Douglas R ^c   Liu, Lu ^b   Osborn, Mark J ^a   Lund, Troy C ^a   Blazar, Bruce R ^a   Wagner, John E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SHRINERS HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 7; COMPLEMENTARY DNA; GENOMIC DNA; MESSENGER RNA;

ARTICLE; BASEMENT MEMBRANE; BLOOD CELL; CELL DIFFERENTIATION; CHILD; CONTROLLED STUDY; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE SILENCING; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; LOSS OF FUNCTION MUTATION; MALE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA; REVERTANT; SCHOOL CHILD; SKIN CELL; SKIN EPITHELIUM; STEM CELL GENE THERAPY; TANDEM REPEAT; TRANSMISSION ELECTRON MICROSCOPY;

CELL DIFFERENTIATION; CHILD; COLLAGEN TYPE VII; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EPIGENESIS, GENETIC; GENES, RECESSIVE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KERATINOCYTES; MALE; MOSAICISM; SKIN;

EID: 84893252380     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.523     Document Type: Article

References (53)

1. T. Aasen A. Raya M.J. Barrero Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes Nat Biotechnol 26 2008 1276 1284
2. N. Almaani N. Nagy L. Liu Revertant mosaicism in recessive dystrophic epidermolysis bullosa J Invest Dermatol 130 2010 1937 1940
3. F. Anokye-Danso C.M. Trivedi D. Juhr Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency Cell Stem Cell 8 2011 376 388
4. T. Ariga M. Yamada Y. Sakiyama A case of Wiskott-Aldrich syndrome with dual mutations in exon 10 of the WASP gene: an additional de novo one-base insertion, which restores frame shift due to an inherent one-base deletion, detected in the major population of the patient’s peripheral blood lymphocytes Blood 92 1998 699 701
5. E.V. Badiavas M. Abedi J. Butmarc Participation of bone marrow derived cells in cutaneous wound healing J Cell Physiol 196 2003 245 250
6. G. Bilousova J. Chen D.R. Roop Differentiation of mouse induced pluripotent stem cells into a multipotent keratinocyte lineage J Invest Dermatol 131 2011 857 864
7. L. Bruckner-Tuderman Dystrophic epidermolysis bullosa: pathogenesis and clinical features Dermatol Clin 28 2010 107 114
8. G. Chen D.R. Gulbranson Z. Hou Chemically defined conditions for human iPSC derivation and culture Nat Methods 8 2011 424 429
9. T. Chino K. Tamai T. Yamazaki Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance Am J Pathol 173 2008 803 814
10. K.D. Choi M. Vodyanik I.I. Slukvin Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells Nat Protoc 6 2011 296 313
11. P. Conget F. Rodriguez S. Kramer Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa Cytotherapy 12 2010 429 431
12. T.N. Darling C. Yee J.W. Bauer Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation J Clin Invest 103 1999 1371 1377
13. M. De Luca G. Pellegrini F. Mavilio Gene therapy of inherited skin adhesion disorders: a critical overview Br J Dermatol 161 2009 19 24
14. N.A. Ellis D.J. Lennon M. Proytcheva Somatic intragenic recombination within the mutated locus BLM can correct the high sister-chromatid exchange phenotype of Bloom syndrome cells Am J Hum Genet 57 1995 1019 1027
15. J.D. Fine Inherited epidermolysis bullosa: past, present, and future Ann N Y Acad Sci 1194 2010 213 222
16. J.D. Fine R.A. Eady E.A. Bauer The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB J Am Acad Dermatol 58 2008 931 950
17. C.T. Freberg J.A. Dahl S. Timoskainen Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract Mol Biol Cell 18 2007 1543 1553
18. A. Fritsch S. Loeckermann J.S. Kern A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy J Clin Invest 118 2008 1669 1679
19. X. Fu X. Sun Can hematopoietic stem cells be an alternative source for skin regeneration? Ageing Res Rev 8 2009 244 249
20. J.J. Gregory Jr. J.E. Wagner P.C. Verlander Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells Proc Natl Acad Sci USA 98 2001 2532 2537
21. M. Gross H. Hanenberg S. Lobitz Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction Cytogenet Genome Res 98 2002 126 135
22. S. Hacein-Bey-Abina C. Von Kalle M. Schmidt LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 Science 302 2003 415 419
23. R. Hirschhorn In vivo reversion to normal of inherited mutations in humans J Med Genet 40 2003 721 728
24. R. Hirschhorn D.R. Yang J.M. Puck Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency Nat Genet 13 1996 290 295
25. S.J. Howe M.R. Mansour K. Schwarzwaelder Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients J Clin Invest 118 2008 3143 3150
26. M. Itoh M. Kiuru M.S. Cairo Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells Proc Natl Acad Sci USA 108 2011 8797 8802
27. M.F. Jonkman H. Scheffer R. Stulp Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion Cell 88 1997 543 551
28. J.S. Kern S. Loeckermann A. Fritsch Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity Mol Ther 17 2009 1605 1615
29. D. Kiritsi J.S. Kern H. Schumann Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa J Med Genet 48 2011 450 457
30. T.S. Kupper R.C. Fuhlbrigge Immune surveillance in the skin: mechanisms and clinical consequences Nat Rev Immunol 4 2004 211 222
31. J.E. Lai-Cheong J.A. McGrath J. Uitto Revertant mosaicism in skin: natural gene therapy Trends Mol Med 17 2011 140 148
32. T.X. Liu N.G. Howlett M. Deng Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis Dev Cell 5 2003 903 914
33. J.R. Lo Ten Foe M.L. Kwee M.A. Rooimans Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance Eur J Hum Genet 5 1997 137 148
34. A. Mankad T. Taniguchi B. Cox Natural gene therapy in monozygotic twins with Fanconi anemia Blood 107 2006 3084 3090
35. K. Okita Y. Matsumura Y. Sato A more efficient method to generate integration-free human iPS cells Nat Methods 8 2011 409 412
36. K. Okita M. Nakagawa H. Hyenjong Generation of mouse induced pluripotent stem cells without viral vectors Science 322 2008 949 953
37. I.H. Park N. Arora H. Huo Disease-specific induced pluripotent stem cells Cell 134 2008 877 886
38. A.M. Pasmooij M. Garcia M.J. Escamez Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa J Invest Dermatol 130 2010 2407 2411
39. A.M. Pasmooij M.F. Jonkman J. Uitto Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapy Discov Med 14 2012 167 179
40. A. Petrova D. Ilic J.A. McGrath Stem cell therapies for recessive dystrophic epidermolysis bullosa Br J Dermatol 163 2010 1149 1156
41. P.H. Schuilenga-Hut H. Scheffer H.H. Pas Partial revertant mosaicism of keratin 14 in a patient with recessive epidermolysis bullosa simplex J Invest Dermatol 118 2002 626 630
42. V. Stephan V. Wahn F. Le Deist Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells N Engl J Med 335 1996 1563 1567
43. S.M. Taapken B.S. Nisler M.A. Newton Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells Nat Biotechnol 29 2011 313 314
44. J. Tolar B.R. Blazar J.E. Wagner Concise review: transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa Stem Cells 29 2011 900 906
45. J. Tolar A. Ishida-Yamamoto M. Riddle Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells Blood 113 2009 1167 1174
46. J. Tolar I.H. Park L. Xia Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome) Blood 117 2011 839 847
47. J. Tolar L. Xia C.J. Lees Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa J Invest Dermatol 133 2012 562 565
48. J. Tolar L. Xia M.J. Riddle Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa J Invest Dermatol 131 2011 848 856
49. J. Uitto J.A. McGrath U. Rodeck Progress in epidermolysis bullosa research: toward treatment and cure J Invest Dermatol 130 2010 1778 1784
50. J.E. Wagner A. Ishida-Yamamoto J.A. McGrath Bone marrow transplantation for recessive dystrophic epidermolysis bullosa N Engl J Med 363 2010 629 639
51. T. Wong L. Gammon L. Liu Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa J Invest Dermatol 128 2008 2179 2189
52. T. Zhao Z.N. Zhang Z. Rong Immunogenicity of induced pluripotent stem cells Nature 474 2011 212 215
53. H. Zhu M.W. Lensch P. Cahan Investigating monogenic and complex diseases with pluripotent stem cells Nat Rev Genet 12 2011 266 275